Lexicon Pharmaceuticals, Inc.

Ownership Transactions Reported by 27 Insiders

Symbol
LXRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2445 Technology Forest Blvd., Suite 1100, The Woodlands, TX

There are no Buy or Sell transactions made by insiders since 12/23/2023

Lexicon Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Artal International S.C.A. Director, 10%+ Owner $357M May 10, 2024
Siren, L.L.C. Director, 10%+ Owner $92.8M Jul 25, 2024
Raymond Debbane Director $17.9M May 13, 2024
Invus US Partners LLC Director, 10%+ Owner $6.09M Aug 5, 2022
Lonnel Coats Chief Executive Officer, Director $3.51M Feb 28, 2024
Jeffrey L. Wade President and COO $1.11M Jul 8, 2024
Alan J. Main EVP, Innov & Chem Sciences $842K Feb 28, 2024
Philippe Amouyal Director $747K May 13, 2024
Brian T. Crum SVP, General Counsel & Secr. $640K Feb 28, 2024
Kenneth B. Kassler-Taub SVP, Regulatory & QA $598K Feb 28, 2024
Christopher J. Sobecki Director $534K May 13, 2024
L. Barker Director $326K May 13, 2024
Wendy McDermott VP, Human Resources $283K Feb 28, 2024
Thomas Garner SVP, Chief Commercial Officer $239K Feb 8, 2024
Judith L. Swain Director $223K May 13, 2024
Robert J. Lefkowitz Director $223K May 13, 2024
Kristen Alexander VP, Finance and Accounting $209K Feb 28, 2024
Craig B. Granowitz SVP, Chief Medical Officer $200K Feb 28, 2024
Kiernan Seth VP, Chief Commercial Officer $104K Feb 28, 2023
Diane E. Sullivan Director $96.4K May 13, 2024
Alan S. Nies Director $43.2K May 21, 2023
Frank Palantoni Director $42.5K May 21, 2023
Lisa DeFrancesco VP, IR and Corp Strategy $0 Oct 2, 2024
Brian Corrigan SVP, Regulatory & QA Aug 12, 2024
Ivan Cheung Director Dec 2, 2024
Michael Exton Chief Executive Officer, Director Jul 8, 2024
Artal Participations S.a r.l. Director, 10%+ Owner Dec 5, 2024

Recent Insider Transactions by Companies or Individuals for Lexicon Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.